Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: Simvastatin and Diastolic Dysfunction [Phase 4]
A Phase 4 clinical trial evaluating simvastatin for diastolic dysfunction in patients with hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-02Clinical Trial Update: Nifedipine (Adalat CR, BAY A1040) High Dose PK/PD Study [Phase 2]
Phase 2 high-dose PK/PD study of nifedipine (Adalat CR) for hypertension has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2010-02-02Clinical Trial Update: Filtered Trial for Telmisartan 40mg Non-responder [Phase 3]
Phase 3 trial update evaluating telmisartan 40 mg in hypertension non-responders. Results were posted February 2010.
-
CLINICAL_TRIALS trial_result · 2010-02-02Clinical Trial Update: Effect of Different Dosages of Dark Chocolate on Arterial Blood Pressure in Cardiovascular High-risk Patients [Phase 4]
A Phase 4 clinical trial evaluating the effects of different dosages of dark chocolate on arterial blood pressure in high-risk cardiovascula…
-
CLINICAL_TRIALS trial_result · 2010-02-01Clinical Trial Update: Filtered Trial for Amlodipine Non-responder [Phase 3]
This is a Phase 3 clinical trial update on amlodipine non-responders in hypertension. Results for the study have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-02-01Clinical Trial Update: COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension [Phase 3]
Phase 3 trial comparing COREG MR to TOPROL-XL on lipid profiles in normolipidemic or mildly dyslipidemic patients with hypertension. The stu…
-
FDA approval · 2010-01-29FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for benazepril hydrochloride from Amneal Pharmaceuticals of New York LLC (generic benazepril hydroch…
-
FDA approval · 2010-01-28FDA Approved: QUINAPRIL — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for Quinapril submitted by Cipla USA Inc. The approval confirms continued availability of Quinapril …
-
FDA approval · 2010-01-28FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approved a supplemental application for enalapril maleate from Taro Pharmaceuticals U.S.A., Inc., authorizing the generic product under …
-
CLINICAL_TRIALS research · 2010-01-27Clinical Trial Update: U-CHAMP: Urban Cardiovascular Health Assessment and Management Program [NA]
This is a trial update for the U-CHAMP urban cardiovascular health assessment and management program. The sponsor is the University of Calga…
-
CLINICAL_TRIALS trial_result · 2010-01-26Clinical Trial Update: Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters
The results of an observational study assessing the safety and efficacy of telmisartan in hypertensive patients across multiple centers have…
-
FDA approval · 2010-01-25FDA Approved: INDAPAMIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for indapamide from Rising Pharma Holdings, Inc., enabling updated labeling for the generic diur…
-
CLINICAL_TRIALS trial_result · 2010-01-22Clinical Trial Update: A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension [Phase 4]
Phase 4 clinical trial evaluating the blood pressure lowering effectiveness and safety of olmesartan medoxomil in adults with hypertension h…
-
CLINICAL_TRIALS trial_result · 2010-01-21Clinical Trial Update: Acupuncture and Laser Acupoint Treatment on Hypertension [Phase 1]
Phase 1 clinical trial evaluating acupuncture and laser acupoint treatment for hypertension; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2010-01-20Clinical Trial Update: Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension [Phase 2]
This Phase 2 trial update from Bayer assesses the effects of Angeliq and Prempro on blood pressure and sodium sensitivity in postmenopausal …
-
CLINICAL_TRIALS trial_result · 2010-01-20Clinical Trial Update: The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension
This clinical trial update presents real-world data on the efficacy and safety of telmisartan in patients with arterial hypertension. The tr…
-
FDA approval · 2010-01-19FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for metoprolol tartrate submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2010-01-19FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)
FDA approved a supplemental application for TOPROL XL (metoprolol succinate) submitted by Melinta Therapeutics, LLC.
-
FDA approval · 2010-01-19FDA Approved: HYDROCHLOROTHIAZIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved an original application for a generic hydrochlorothiazide from Unichem Pharmaceuticals (USA), Inc. under an ANDA; the produ…
-
CLINICAL_TRIALS trial_result · 2010-01-18Clinical Trial Update: Open Label Study Telmisartan and Amlodipine in Hypertension [Phase 3]
An open-label Phase 3 trial evaluating the combination of telmisartan and amlodipine for hypertension, with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-01-18Clinical Trial Update: Intravenous Beta-blockade for Improvement of Autonomic Activity
A completed clinical trial evaluated intravenous beta-blockade for improving autonomic activity in patients with hypertension and tachycardi…
-
FDA approval · 2010-01-14FDA Approved: DOXAZOSIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for doxazosin submitted by Mylan Pharmaceuticals.
-
CLINICAL_TRIALS research · 2010-01-14Clinical Trial Update: Aliskiren and Muscle Sympathetic Nerve Activity [Phase 4]
Phase 4 clinical trial update evaluating aliskiren's effect on muscle sympathetic nerve activity in individuals with chronic kidney disease …
-
CLINICAL_TRIALS trial_result · 2010-01-14Clinical Trial Update: Pre-ESRD Syndrome in High Risk African Americans [NA]
The NIDDK-sponsored clinical trial on pre-ESRD syndrome in high-risk African Americans has been terminated; the listed condition studied is …
-
FDA approval · 2010-01-13FDA Approved: CARDENE IV — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for Cardene IV, a new intravenous formulation of nicardipine hydrochloride by Baxter Healthcare …